Table of Contents
Cardiovascular Psychiatry and Neurology
Volume 2009, Article ID 618586, 8 pages
http://dx.doi.org/10.1155/2009/618586
Research Article

Pharmacological Characterization of Inositol 1,4,5-tris Phosphate Receptors in Human Platelet Membranes

Department of Psychiatry, The Psychiatric Institute, University of Illinois at Chicago, Chicago, IL 60612, USA

Received 21 May 2009; Accepted 12 July 2009

Academic Editor: Kenji Hashimoto

Copyright © 2009 Yogesh Dwivedi and Ghanshyam N. Pandey. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Nishizuka, “Membrane phospholipid turnover, receptor function and protein phosphorylation,” Progress in Brain Research, vol. 56, pp. 287–301, 1982. View at Google Scholar
  2. R. H. Michell, C. J. Kirk, L. M. Jones, C. P. Downes, and J. A. Creba, “The stimulation of inositol lipid metabolism that accompanies calcium mobilization in stimulated cells: defined characteristics and unanswered questions,” Philosophical Transactions of the Royal Society of London B, vol. 296, no. 1080, pp. 123–138, 1981. View at Google Scholar
  3. M. J. Berridge, “Inositol trisphosphate and calcium signaling,” Nature, vol. 361, p. 316, 1993. View at Google Scholar
  4. M. J. Berridge and R. F. Irvine, “Inositol phosphates and cell signaling,” Nature, vol. 341, no. 6239, pp. 197–205, 1989. View at Google Scholar
  5. P. F. Worley, J. M. Baraban, S. Supattapone, V. S. Wilson, and S. H. Snyder, “Characterization of inositol trisphosphate receptor binding in brain regulation by pH and calcium,” Journal of Biological Chemistry, vol. 262, no. 25, pp. 12132–12136, 1987. View at Google Scholar
  6. G. Guillemette, T. Balla, A. J. Baukal, and K. J. Catt, “Characterization of inositol 1,4,5-triphosphate receptors and calcium mobilization in a hepatic plasma membrane fraction,” Journal of Biological Chemistry, vol. 263, no. 10, pp. 4541–4548, 1988. View at Google Scholar
  7. C. C. Chadwick, A. Saito, and S. Fleischer, “Isolation and characterization of the inositol trisphosphate receptor from smooth muscle,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 6, pp. 2132–2136, 1990. View at Google Scholar
  8. T. V. Murphy, L. M. Broad, and C. J. Garland, “Characterisation of inositol 1,4,5-trisphosphate binding sites in rabbit aortic smooth muscle,” European Journal of Pharmacology, vol. 290, no. 2, pp. 145–150, 1995. View at Google Scholar
  9. A. L. Willcocks, R. A. J. Challiss, and S. R. Nahorski, “Characteristics of inositol 1,4,5-trisphosphate binding to rat cerebellar and bovine adrenal cortical membranes: evidence for the heterogeneity of binding sites,” European Journal of Pharmacology, vol. 189, no. 2-3, pp. 185–193, 1990. View at Publisher · View at Google Scholar
  10. R. A. J. Challiss, A. L. Willcocks, B. V. Potter, and S. R. Nahorski, “Comparison of inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate binding sites in cerebellum,” Biochemical Society Transactions, vol. 19, no. 2, p. 151S, 1991. View at Google Scholar
  11. C. A. Ross, S. K. Danoff, M. J. Schell, S. H. Snyder, and A. Ullrich, “Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 10, pp. 4265–4269, 1992. View at Publisher · View at Google Scholar
  12. O. Blondel, J. Takeda, H. Janssen, S. Seino, and G. I. Bell, “Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues,” Journal of Biological Chemistry, vol. 268, no. 15, pp. 11356–11363, 1993. View at Google Scholar
  13. A. R. Maranto, “Primary structure, ligand binding and localization of human type 3 inositol 1,4,5-trisphosphate receptor expressed in intestinal epithelium,” Journal of Biological Chemistry, vol. 269, no. 2, pp. 1222–1230, 1994. View at Google Scholar
  14. T. Pozzan, R. Rizzuto, P. Volpe, and J. Meldolesi, “Molecular and cellular physiology of intracellular calcium stores,” Physiological Reviews, vol. 74, no. 3, pp. 595–636, 1994. View at Google Scholar
  15. L. F. Brass and S. K. Joseph, “A role for inositol triphosphate in intracellular Ca2+ mobilization and granule secretion in platelets,” Journal of Biological Chemistry, vol. 260, no. 28, pp. 15172–15179, 1985. View at Google Scholar
  16. M. Eberhard and P. Erne, “Regulation of inositol 1,4,5-trisphosphate-induced calcium release by inositol 1,4,5-trisphosphate and calcium in human platelets,” Journal of Receptor and Signal Transduction Research, vol. 15, no. 1–4, pp. 297–309, 1995. View at Google Scholar
  17. H. Kaiya, M. Ofuji, M. Nozaki, and K. Tsurumi, “Platelet prostaglandin E1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregation,” Psychopharmacology Bulletin, vol. 26, no. 3, pp. 381–381, 1990. View at Google Scholar
  18. M. Mikuni, I. Kusumi, A. Kagaya, Y. Kuroda, H. Mori, and K. Takahashi, “Increased 5HT2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients,” Progress in Neuropsychopharmacology and Biological Psychiatry, vol. 15, no. 1, pp. 49–61, 1991. View at Publisher · View at Google Scholar
  19. G. N. Pandey, S. C. Pandey, and J. M. Davis, “Effect of desipramine on inositol phosphate formation and inositol phospholipids in rat brain and human platelets,” Psychopharmacology Bulletin, no. 3, pp. 255–261, 1991. View at Google Scholar
  20. S.-B. Hwang, “Specific binding of tritium-labeled inositol 1,4,5-trisphosphate to human platelet membranes: ionic and GTP regulation,” Biochimica et Biophysica Acta, vol. 1064, no. 2, pp. 351–359, 1991. View at Publisher · View at Google Scholar
  21. M. B. Feinstein, J. J. Egan, R. I. Sha'afi, and J. White, “The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin),” Biochemical and Biophysical Research Communications, vol. 113, no. 2, pp. 598–604, 1983. View at Google Scholar
  22. G. A. McPherson, “Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC,” Journal of Pharmacological Methods, vol. 14, no. 3, pp. 213–228, 1985. View at Publisher · View at Google Scholar
  23. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the folin phenol reagent,” Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar
  24. M. A. Varney, J. Rivera, A. Lopez Bernal, and S. P. Watson, “Are there subtypes of the inositol 1,4,5-trisphosphate receptor?” Biochemical Journal, vol. 269, no. 1, pp. 211–216, 1990. View at Google Scholar
  25. R. J. Mourey, A. Verma, S. Supattapone, and S. H. Snyder, “Purification and characterization of the inositol 1,4,5-trisphosphate receptor protein from rat vas deferens,” Biochemical Journal, vol. 272, no. 2, pp. 383–389, 1990. View at Google Scholar
  26. I. Bezprozvanny, J. Watras, and B. E. Ehrlich, “Bell-shaped calcium-response curves of Ins(1,4,S)P3 and calcium-gated channels from endoplasmic reticulum of cerebellum,” Nature, vol. 351, no. 6329, pp. 751–754, 1991. View at Google Scholar
  27. D. M. Delfert, S. Hill, and H. A. Pershadsingh, “Myo-inositol 1,4,5-triphosphate mobilizes Ca2+ from isolated adipocyte endoplasmic reticulum but not from plasma membranes,” Biochemical Journal, vol. 236, no. 1, pp. 37–44, 1986. View at Google Scholar
  28. S. K. Danoff, S. Supattapone, and S. H. Snyder, “Characterization of a membrane protein from brain mediating the inhibition of inositol 1,4,5-trisphosphate receptor binding by calcium,” Biochemical Journal, vol. 254, no. 3, pp. 701–705, 1988. View at Google Scholar
  29. G. A. Mignery, P. A. Johnston, and T. C. Sudhof, “Mechanism of Ca2+ inhibition of inositol 1,4,5-trisphosphate (Ins P3) binding to the cerebellar Ins P3 receptor,” Journal of Biological Chemistry, vol. 267, no. 11, pp. 7450–7455, 1992. View at Google Scholar
  30. P. F. Worley, J. M. Baraban, J. S. Colvin, and S. H. Snyder, “Inositol trisphosphate receptor localization in brain: variable stoichiometry with protein kinase C,” Nature, vol. 325, no. 6100, pp. 159–161, 1987. View at Google Scholar
  31. T. Tohmatsu, A. Nishida, S. Nagao, S. Nakashima, and Y. Nozawa, “Inhibitory action of cyclic AMP on inositol 1,4,5-trisphosphate-induced Ca2+ release in saponin-permeabilized platelets,” Biochimica et Biophysica Acta, vol. 1013, no. 2, pp. 190–193, 1989. View at Google Scholar
  32. T. M. Quinton and W. L. Dean, “Cyclic AMP-dependent phosphorylation of the inositol-1,4,5-trisphosphate receptor inhibits Ca2+ release from platelet membranes,” Biochemical and Biophysical Research Communications, vol. 184, no. 2, pp. 893–899, 1992. View at Publisher · View at Google Scholar
  33. R. C. Shelton, “The molecular neurobiology of depression,” Psychiatric Clinics of North America, vol. 30, no. 1, pp. 1–11, 2007. View at Publisher · View at Google Scholar
  34. Y. Dwivedi, H. S. Rizavi, P. K. Shukla et al., “Protein kinase a in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits,” Biological Psychiatry, vol. 55, no. 3, pp. 234–243, 2004. View at Publisher · View at Google Scholar